| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/26/2008 | US20080152642 Aiolos, Helios, Daedalos and Ikaros: genes, polypeptides, regulatory elements and uses thereof |
| 06/26/2008 | US20080152641 Inhibitors of Siderophore Biosynthesis in Fungi |
| 06/26/2008 | US20080152640 administering drugs comprising inhibitor of ATP-binding cassette transporters (ABC-transporter), such as verapamil or valspodar, for the treatment of arthritis; drug screening |
| 06/26/2008 | US20080152631 Cancer Antigen Peptides Derived from Wt1 |
| 06/26/2008 | US20080152620 Hemopoietic cytokine for use in diagnosis, prevention and treatment of skin and respiratory disorders |
| 06/26/2008 | US20080152615 Vaccine containing immunopotentiator; administering to animal together with antigen having low immunogenicity; side effect reduction; preventive or curative vaccine for non-contagious chronic diseases and cancers of bladder, brain, glioma, breasts, lungs, colons, ovaries, head, and neck; antitumor agents |
| 06/26/2008 | US20080152587 TARGETED BINDING AGENTS DIRECTED TO uPAR AND USES THEREOF |
| 06/26/2008 | US20080152586 Protein complexes comprising three or more polypeptides, each having multiple immunoglobulin like domains, which associate to form target binding regions, for use as therapeutic, diagnostic or imaging agents |
| 06/26/2008 | CA2839162A1 Methods for the treatment of il-1-.beta. related diseases |
| 06/26/2008 | CA2766173A1 Method for replicating influenza virus in culture |
| 06/26/2008 | CA2709411A1 Binding agents to the integrin alpha-11 subunit, and uses thereof |
| 06/26/2008 | CA2698307A1 Histophilus somni antigens, compositions and methods of use |
| 06/26/2008 | CA2673592A1 Methods for the treatment of il-1.beta. related diseases |
| 06/26/2008 | CA2673331A1 Amino acid sequences directed against gpcrs and polypeptides comprising the same for the treatment of gpcr-related diseases and disorders |
| 06/26/2008 | CA2672828A1 Methods of treatment |
| 06/26/2008 | CA2672826A1 Circular ccr5 peptide conjugates and uses thereof |
| 06/26/2008 | CA2672772A1 Oral delivery of polypeptides |
| 06/26/2008 | CA2672770A1 Amino acid sequences directed against fc receptors and polypeptides comprising the same for the treatment of fcr-related diseases and disorders |
| 06/26/2008 | CA2672622A1 Human antibodies to human delta like ligand 4 |
| 06/26/2008 | CA2671869A1 Method for replicating influenza virus in culture |
| 06/26/2008 | CA2671865A1 Canine thymic stromal lymphopoietin protein and uses thereof |
| 06/26/2008 | CA2671734A1 Vegf-specific antagonists for adjuvant and neoadjuvant therapy and the treatment of early stage tumors |
| 06/26/2008 | CA2671538A1 Engineered anti-tslp antibody |
| 06/26/2008 | CA2670992A1 Antagonist anti-notch3 antibodies and their use in the prevention and treatment of notch3-related diseases |
| 06/26/2008 | CA2670836A1 Treatment of pigs with pcv2 antigen |
| 06/26/2008 | CA2669921A1 Human monoclonal antibodies to btla and methods of use |
| 06/25/2008 | EP1935991A2 Nucleic acid vaccines for prevention of flavivirus infection |
| 06/25/2008 | EP1935979A2 Antigenic meningococcal peptides |
| 06/25/2008 | EP1935431A2 Cancer treatments by using a combination of an antibody against her2 and interleukin-2 |
| 06/25/2008 | EP1934605A2 Glycosylated polypeptides produced in yeast mutants and methods of use thereof |
| 06/25/2008 | EP1934598A2 Treatment and diagnosis of obligate intracellular pathogens |
| 06/25/2008 | EP1934262A1 Antibodies to complementary peptides of thrombin or portions thereof |
| 06/25/2008 | EP1934260A2 Compositions and methods for treating proliferative disorders |
| 06/25/2008 | EP1934259A2 Nanobodies and polypeptides against egfr and igf-ir |
| 06/25/2008 | EP1934247A1 Novel sea lice vaccine |
| 06/25/2008 | EP1934246A2 Matrix metalloproteinase 11 vaccine |
| 06/25/2008 | EP1933874A2 Targeted biocides |
| 06/25/2008 | EP1933873A2 Methods and compositions for use in treatment of patients with autoantibody positive diseases |
| 06/25/2008 | EP1933872A2 Anti-glypican-3 antibody |
| 06/25/2008 | EP1933871A2 Human monoclonal antibodies to activin receptor-like kinase-1 |
| 06/25/2008 | EP1933870A2 Treatment of b cell diseases using anti-germline antibody binding agents |
| 06/25/2008 | EP1933869A2 Use of il-23 and il-17 antagonists to treat autoimmune ocular inflammatory disease |
| 06/25/2008 | EP1933868A2 Anti-cd3 antibody formulations |
| 06/25/2008 | EP1933867A1 Solid vaccine formulation |
| 06/25/2008 | EP1933866A2 Canine influenza virus and related compositions and methods of use |
| 06/25/2008 | EP1933865A2 Immunogenic capsule composition for use as a vaccine component against campylobacter jejuni |
| 06/25/2008 | EP1933864A2 Antibodies as t cell receptor mimics, methods of production and uses thereof |
| 06/25/2008 | EP1616950B1 Peptide having htlv-1-specific ctl-inducing activity |
| 06/25/2008 | EP1425404B1 Vaccinia virus mva-e3l-knockout-mutants and use thereof |
| 06/25/2008 | EP1278535B1 Uses of tgap7 for the modulation of leucocyte activation |
| 06/25/2008 | EP1261320B1 Micellar pharmaceutical compositions for buccal and pulmonary application |
| 06/25/2008 | EP1230261B1 Ny-eso-1 nonapeptide derivatives, and uses thereof |
| 06/25/2008 | EP1204752B1 Immunogenic polypeptides derived from moraxella catarrhalis and uses thereof |
| 06/25/2008 | EP1190055B1 Human endogenous retrovirus |
| 06/25/2008 | EP1126874B2 Multicomponent meningococcal vaccine |
| 06/25/2008 | EP1117687B1 Compositions and methods for wt1 specific immunotherapy |
| 06/25/2008 | EP1107789B1 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage |
| 06/25/2008 | EP1033996B1 Prevention and treatment of amyloidogenic disease |
| 06/25/2008 | EP1015027B1 Process for preparing conjugate vaccines including free protein |
| 06/25/2008 | EP0988051B1 Lyme combination compositions and uses |
| 06/25/2008 | EP0859625B1 Composition and methods for enhancing immune responses mediated by antigen-presenting cells |
| 06/25/2008 | CN101208105A Multiple antigenic agents and methods for using the same |
| 06/25/2008 | CN101208104A Nipah virus vaccines |
| 06/25/2008 | CN101208103A 免疫原性组合物 The immunogenic composition |
| 06/25/2008 | CN101208102A Immunogenic composition |
| 06/25/2008 | CN101208101A 免疫原性组合物 The immunogenic composition |
| 06/25/2008 | CN101208100A Anti-malaria vaccine |
| 06/25/2008 | CN101208075A Liposome composition for induction of immunity |
| 06/25/2008 | CN101205255A Anti CD20 tetravalent antibody, preparation method and uses thereof |
| 06/25/2008 | CN101204584A Tumor vaccine using salmonella as carrier and preparation method thereof |
| 06/25/2008 | CN101204582A Hepatitis B fusion protein multiva lentvaccine, preparation method and uses thereof |
| 06/25/2008 | CN101204581A Real time individual poultry and eggs antibody preparation for AIDS virus, preparation method and application thereof |
| 06/25/2008 | CN101204580A Application of Vibrio alginolyticus-OmpA as animal immunity regulator |
| 06/25/2008 | CN101204374A Coating compound polyvalent high efficient yolk antibody |
| 06/25/2008 | CN101204364A Delivery system and application of chitosan mucosa compromising mucosal adjuvant |
| 06/25/2008 | CN100397082C HCV-free-blood external preparing method |
| 06/25/2008 | CN100397081C Diagnosing tumorigenicity and determining resistance to the antineoplastic therapy |
| 06/25/2008 | CN100396700C Recombinant fusion protein of mycobacterium tuberculosis Ag85B antigen and human IL-2, and its uses |
| 06/25/2008 | CN100396699C Transgenic mammal carrying GANP gene transferred thereinto and utilization thereof |
| 06/25/2008 | CN100396698C New mastocancer related protein and its specificity multiclone antibody |
| 06/25/2008 | CN100396697C New mastocancer related protein and its specificity multiclone antibody |
| 06/24/2008 | US7392233 Image searching system, image searching method, and a recording medium storing an image searching program |
| 06/24/2008 | US7392141 Polypeptides; genetic engineering |
| 06/24/2008 | US7390892 nucleotide sequences and genes that code for proteins as well as antibodies raised against such proteins; enzymes used in screening assays to identify antiprotozoa agents; antibodies use to protect animals from disease caused by parasites |
| 06/24/2008 | US7390891 Affect aging and/or proliferation of cells in the human |
| 06/24/2008 | US7390888 Dendritic cell potentiation |
| 06/24/2008 | US7390885 Humanized collagen antibodies and related methods |
| 06/24/2008 | US7390884 Lymphoid chemokines in the diagnosis, monitoring and treatment of inflammatory disease |
| 06/24/2008 | US7390882 Compositions and methods for the diagnosis and treatment of tumor |
| 06/24/2008 | US7390881 first component is the modified antigenic ectodomain of measles virus hemagglutinin protein, second component fused to first component that binds a surface protein of human immunodeficiency virus; for treating HIV infection and other therapeutic targets against which it is difficult to develop vaccines |
| 06/24/2008 | US7390879 Conjugation/biochemical; fibroblast growth factors |
| 06/24/2008 | US7390873 Microbiocides; bactericides |
| 06/24/2008 | US7390872 fusion proteins has high transduction potential, inhibits the NF- kappa B pathway; biodrugs as antiinflammatory agents, viricides, antiproliferative agents, immunostimulants |
| 06/24/2008 | US7390871 Isolated polypeptide as antitumor agents, anticarcinogenic agents; amino acid sequences binding to major histocompatibility complex (MHC); tumor antigen induces killer T cells against cancer; anti-cancer vaccines, biodrugs |
| 06/24/2008 | US7390870 Immune-enhancing peptides |
| 06/24/2008 | US7390834 Increased or improved bioavailability of the active agents for oral, intracolonic, pulmonary, and other routes of administrations |
| 06/24/2008 | US7390646 Bacterial vectors and methods of use thereof |
| 06/24/2008 | US7390630 Method of identifying a compound that selectively inhibits cytokine-stimulated T cell induced production of TNF-alpha by monocytes |
| 06/24/2008 | US7390626 Methods and kit for diagnosing tick borne illnesses |
| 06/24/2008 | US7390619 Creating a library of mutant polynucleotides from at least two nucleic acids encoding a B7-1 (CD80) protein; expressing in cells and screening for the optimized polynucleotide; increased T-cell response, increased activity through CD28 and a decreased activity through CTLA-4 |